Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 849 of 1,261
  1. US 8552167

    Multifunctional aptamer-nucleic acid nanostructures for tumor-targeted killing

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  2. US 8552150

    MART-1 T cell receptors

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  3. US 8552006

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  4. US 8552198

    Benzimidazole compound crystal

    Takeda Pharmaceutical Company Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  5. US 8552147

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  6. US 8552018

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  7. US 8551936

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  8. US 8551526

    Preparation of drug particles using evaporation precipitation into aqueous solutions

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  9. US 8551467

    Replenishment and enrichment of ocular surface lubrication

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  10. US 8551448

    Rotanone analogs: method of preparation and use

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  11. US 8551935

    Benefit agent containing delivery particle

    Appleton Papers Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  12. US 8551966

    Chemical compounds

    University College Cardiff Consultants Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  13. US 8551965

    Anti-viral pyrimidine nucleoside analogues

    University College Cardiff Consultants Limited · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  14. US 8551964

    Hsp90 inhibitors with modified toxicity

    The Regents of the University of Colorado · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  15. US 8551997

    Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  16. US 8551978

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  17. US 8551945

    Methods and compositions for treating neuropathies

    Sangamo Biosciences, Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  18. US 8551726

    Method of modulating HSF-1

    Northwestern University · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  19. US 8551536

    Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  20. US 8552034

    Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  21. US 2013261160

    METHOD OF PREPARATION OF METAXALONE

    IACOANGELI TOMMASO [IT] · Granted Oct 3, 2013 · Expires Sep 28, 2033

    granted
  22. US 8546364

    Stabilized steroid composition and method for its preparation

    Precision Dermatology, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  23. US 8545885

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  24. US 8546371

    Nanoparticle formulated glycolipid antigens for immunotherapy

    The Board of Regents of the University of Texas System · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.